Latest news
Phase III SKYSCRAPER-03 trial finds no added benefit from combination immunotherapy in unresectable stage III lung cancer - London Daily NewsLondon Daily News · Sat, 08 Aug 2026 08:19:23 GMTSex Differences in COVID-19 Mortality Fades After Vaccine Rollout - Drug TopicsDrug Topics · Thu, 06 Aug 2026 18:14:46 GMT